Biospecifics - InvestorRoom http://investors.biospecifics.com/ BioSpecifics Technologies Corp. Initiates Phase 1 Clinical Trial of XIAFLEX for Treatment of Uterine Fibroids http://investors.biospecifics.com/2017-04-18-BioSpecifics-Technologies-Corp-Initiates-Phase-1-Clinical-Trial-of-XIAFLEX-for-Treatment-of-Uterine-Fibroids Tue, 18 Apr 2017 08:00:00 -0400 http://investors.biospecifics.com/2017-04-18-BioSpecifics-Technologies-Corp-Initiates-Phase-1-Clinical-Trial-of-XIAFLEX-for-Treatment-of-Uterine-Fibroids BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference http://investors.biospecifics.com/2017-03-29-BioSpecifics-Technologies-Corp-to-Present-at-the-16th-Annual-Needham-Healthcare-Conference Wed, 29 Mar 2017 16:30:00 -0400 http://investors.biospecifics.com/2017-03-29-BioSpecifics-Technologies-Corp-to-Present-at-the-16th-Annual-Needham-Healthcare-Conference BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2016 Financial Results http://investors.biospecifics.com/2017-03-15-BioSpecifics-Technologies-Corp-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results Wed, 15 Mar 2017 08:00:00 -0400 http://investors.biospecifics.com/2017-03-15-BioSpecifics-Technologies-Corp-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results BioSpecifics Technologies Corp. to Present at NobleCon13 - Noble Capital Markets' Thirteenth Annual Investor Conference http://investors.biospecifics.com/2017-01-24-BioSpecifics-Technologies-Corp-to-Present-at-NobleCon13-Noble-Capital-Markets-Thirteenth-Annual-Investor-Conference Tue, 24 Jan 2017 16:30:00 -0500 http://investors.biospecifics.com/2017-01-24-BioSpecifics-Technologies-Corp-to-Present-at-NobleCon13-Noble-Capital-Markets-Thirteenth-Annual-Investor-Conference BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients with Cellulite http://investors.biospecifics.com/2016-11-17-BioSpecifics-Technologies-Corp-Announces-Positive-Data-from-Phase-2b-Study-of-CCH-in-Patients-with-Cellulite Thu, 17 Nov 2016 16:05:00 -0500 http://investors.biospecifics.com/2016-11-17-BioSpecifics-Technologies-Corp-Announces-Positive-Data-from-Phase-2b-Study-of-CCH-in-Patients-with-Cellulite